Skip to content
MCAP $2.20T ▼-1.84%
BTC $64,509 ▼-0.31%
ETH $1,821 ▲+0.65%
BNB $587.40 ▼-0.48%
XRP $0.953 ▼-0.44%
SOL $70.87 ▼-0.43%
DOGE $0.0588 ▲+0.45%
ADA $0.152 ▼-0.50%
TRX $0.3050 ▲+0.31%
LINK $9.14 ▼-0.65%
AVAX $7.12 ▼-0.66%
HYPE $66.76 ▼-0.73%
DOT $0.728 ▼-0.67%
Bruno Delahaye BD

Guest profile

Bruno Delahaye

Chief Growth Officer at Neurochain

Bruno Delahaye is Chief Growth Officer at Neurochain, a blockchain technology company.

He was interviewed at CES 2019 to discuss the company's developments and initiatives for early 2019.

1Interview
2019First on the show
Jan 2019Latest appearance
19 minOn camera
18:57 Latest interview · Jan 9, 2019Bruno Delahaye on Neurochain's 2019 developmentsWatch the episode →

Key points

  • Neurochain is a next-generation blockchain protocol designed to address scalability, energy consumption, and transaction speed issues for real-world applications.
  • The project raised approximately 15,000 ETH during its ICO between March 15 and April 15, 2018, and delivered its testnet on October 31, 2018.
  • Neurochain maintained technical commitments despite the 2018 crypto downturn by reducing marketing activities and planning to use token reserves for funding.
  • The team is targeting mainnet launch by mid-February 2019 and is listed on IDEX, System Coin, and Who Will Be Next exchanges.
  • Neurochain positioned itself at CES 2019 to attract manufacturing and enterprise companies seeking blockchain solutions for competitive advantage.

In their own words

“We launched the project through an ICO which we did between the 15th of March and 15th of April in 2018 and we raised about 15,000 ether at that time.”
▶ Watch at 1:59Jan 2019 · Bruno Delahaye on Neurochain's 2019 developments

Browse all interviews

CCS Insider · free, twice a week

New founder interviews in your inbox

The week's interviews and the key takeaways, twice a week from CCS Insider.

Readers in 160+ countries. No spam, unsubscribe anytime.